NEW YORK, NY / ACCESSWIRE / September 11, 2019 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paysign, Inc.(“Paysign” or the “Company”) (NASDAQ:PAYS). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: www.bgandg.com/pays.
The investigation concerns whether Paysign and certain of its officers and/or directors have violated federal securities laws.
On September 9, 2019, Paysign announced a revision to its revenue guidance for fiscal year 2019, advising investors that “[t]otal revenue is now expected to be in the range of $35.0 million to $37.0 million,” compared to the Company’s previous guidance of $38.0 million to $40.0 million. Paysign stated that “[t]he revised guidance primarily reflects delays in onboarding of new plasma industry programs planned for the first and second quarters of 2019.” On this news, Paysign’s stock price fell $2.57 per share, or 21.35%, to close at $9.47 per share on September 9, 2019.
If you are aware of any facts relating to this investigation, or purchased Paysign shares,you can assist this investigation by visiting the firm’s site: www.bgandg.com/pays. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]
SOURCE: Bronstein, Gewirtz & Grossman, LLC